Natural killer (NKI cells are characterized by their ability t o mediate spontaneous cytotoxicity against susceptible tumor cells and infected cells. They differentiate from hematopoietic progenitor cells. Patients with X-linked severe combined immunodefiency (SCID XI) carry mutations in the yc cytokine receptor gene that result in lack of both T and NK cells. To assess the role of interleukin-2 (IL-21, IL-7, and IL-15 cytokines, which share yc receptor subunit, in NK cell differentiation, we have studied NK cell differentiation from cord blood CD34 (+) cells in the presence of either stem cell factor (SCFI, IL-2, and 11-7 or SCF and IL-15. The former cytokine combination efficiently induced CD34 (+) CD7 (+) cord blood cells t o proliferate and mature into NK cells, while the latter was also able t o induce NK cell differentiation from more immature CD34 (+) CD7 (-1 cord blood cells. NK cells expressed
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EVERE COMBINED immunodeficiency-X1 (SCID-X1)
S is an X-linked immunodeficiency characterized by defective T and natural killer (NK) cell differentiation.' It is caused by mutations in the yc encoding gene.' Several cytokin receptors, ie, the interleukin-2 (IL-2), IL-4, IL-7, IL-9, and IL-15 receptors share the yc chain. 3 It is now thought that the profound and early block in T-cell differentiation is caused mainly by abnormal signal transduction after IL-7 interaction with its receptor. Indeed, IL-7 (-), IL-7R a (-) and yc (-) mice exhibit a very similar, though not absolutely identical, p h e n~t y p e ,~.~ whereas IL-2 (-), IL-4 (-) mice? as well as patients with an immunodeficiency causing lack of IL-2 production, exhibit mature T cells in the periphery?" The mechanism underlying defective NK cell differentiation in yc (-) patients and mice remains less well understood. It has been previously reported that human CD34+ lineage( -) hematopoietic progenitor cells could differentiate into functional NK cells after a 3-to 5-week period of culture in the presence of stromal cells and IL-2." It was later shown that stromal cells could be replaced by SCF & IL-3 and IL-7122'3 and by SCF and IL-15.I4 Mrozek et all4 have recently shown that IL-15 is produced by human bone marrow stromal cells and that it can induce CD34+ progenitor cells to differentiate into CD3-CD56+ NK cells.I4 Mature natural killer cells exhibit the IL-2R , B and yc chains shared between IL-2 and IL-15. The latter cytokine is able to induce highly efficient proliferation of NK cells, as well as cell activation leading to high index cytotoxic activity and cytokine produ~tion.'~.~~ Therefore, at least three cytokines whose receptor contain yc chain, ie, IL-2, IL-7, and IL-15 could play a role in NK cell differentiation.
To further understand the roles of IL-2, IL-7, and IL-15 in NK cell differentiation and as a preclinical step towards treatment by gene transfer of SCID X1, we have assessed the potential of IL-2 and IL-7 with SCF and of IL-15 with SCF to induce cord blood CD34 progenitor cell differentiation into NK cells. We then evaluated NK cell differentiation in the same culture conditions of SCID X1 marrow cells following retroviral-mediated yc gene transfer that was pre-CD56 and efficiently killed K562 target cells. These results show that IL-15 could play an important role in the maturation of NK cell from cord blood progenitors. Following retroviral-mediated gene transfer of yc into SCID X1 bone marrow progenitors, it was possible t o reproduce a similar pattern of NK cell differentiation in two SCID-X1 patients with SCF + IL-2 + IL-7 and more efficiently in one of them with SCF + IL-15. These results strongly suggest that the yc chain transduces major signal(s) involved in NK cell differentiation from hematopoietic progenitor cells and that 11-15 interaction with yc is involved in this process at an earlier step than IL-2/IL-7 interactions of yc are. It also shows that gene transfer into hematopoietic progenitor cells could potentially restore NK cell differentiation in SCID X I patients.
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viously used successfully for yc gene transfer into yc (-) SCID X1 B cells."
MATERIALS AND METHODS
Cell preparation. Control cells were obtained from human umbilical cord blood following delivery. SCID-XI bone marrow cells were obtained from two patients (P1 and P2). Mutations of the ycencoding gene were characterized in both SCID-X1 patients. In P1, a missense mutation changed a cysteine to a glycine at position 62 in the extracellular region of the molecule. This mutation did not modify yc chain transcription. In patient P2, a deletion of the yc gene led to an absence of yc transcription. yc chain expression was undetectable at the surface of both patients' B lymphocytes." In patient PI peripheral blood, the lymphocyte count was 1,98O/~L, CD3' cells 2%, CD19' 99%, and CD16' 0%. In patient P2, the lymphocyte count was 800/pL, CD3' cells 2%, CD19' 64%. and CD16' 2%.
Patients' bone marrow samples were obtained at the ages of 7 and 13 months, respectively. They were collected under general anesthesia indicated for central line insertion for parenteral nutrition. Informed consent from parents was obtained.
Mononuclear cells from umbilical cord blood, isolated by density Human yc chain cDNA extending from the initiation codon ATG (nucleotides numbered 1 to 11 14) was generated by reverse transcription polymerase chain reaction (RT-PCR) from mRNA of control B-cell lines. Forward primer S'-GCAAGCGACATGTTGAAGCC-3', and reverse primer: S'-GAGGATCCGGGTTCAGGllTCAG-3' contain AFL I11 and BanzHI site, respectively for yc chain insertion in the retroviral vector. Correct yc sequence was assessed by direct sequencing of the entire PCR amplified fragment. Human yc chain was then inserted at the Nco I, BainHI site of the MFG (B2)Mo-LTR vector'* MFG (B2), which uses the Moloney murine leukemia virus (MO-MLV) LTRs for transcription of the viral genome and contains the B2 mutation corresponding to a single G to A transition at position + 160 of the MO-MLV sequence." This vector, named MFG (B2)-yc, does not contain a selection marker.
Retroviral producer cell lines were generated by cotransfecting the MFG (B2)-yc plasmid with the plasmid pSV2-neo into the amphotropic packaging cell line $ CRIP as previously described.'" Two days later, the transduced cells were diluted 10 times and placed under G418 (Geneticin; GIBCOBRL) selection at 0.8 to 1 mg/mL active metabolite until individual resistant colonies formed. Titration was performed by infecting S X IO5 NIH3T3 cells with 0.5 mL of a 24-hour supernatant from the virus-producing clones in the presence of 8 mglmL of Polybrene (Sigma Chemical Co, St Louis, MO). Thirty clones were screened for high-titer virus production by Southern blot analysis. Southern blot analysis confirmed the presence of an "arranged proviral genome from these producer clones and
Retroviral vector and virus-producing cell line.
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were used to determine the number of proviral copies integrated in the target population. The clone that presented the highest transmission efficiency of virus for transduction of NIH3T3 cells was in the range of 0.5 copy of provirus per cell. This clone was thus used in the experiments described below. Supernatants from producer clones were also tested for the presence of replication-competent virus by using a vinis mobilization assay" and were found negative.
Rrtroiircrl rrrrrisdrrctiori protocol of SCID-XI rrioiiorirrclmr boric inorrow cells (SCID-XI RMC). SCID-X I BMC were prestimulated with SCF (100 nglmL: kindly provided by Amgen. Thousand Oaks. CA). IL-3 (20 nglmL: kindly provided by Sandoz. Basel. Switzerland). and IL-6 (20 nglmL) at 37°C. 5% C 0 2 for 24 to 36 hours. These cells were then cocultured with MFG (B2)-yc adherent producer cells previously irradiated at 30 Gy in the presence of the same cytokines and Polybrene (8 mg/mL) for 3 days.
Crtltirre coriditinris of heriicrtopoietic cells in N K cell cliffereriticitiori nssriy. Aliquots of 200 mL of the myelocult medium (Stem-Cell Technologies. Vancouver. Canada) containing 50 ng/mL recombinant human (rhu) SCF (Amgen) 500 UlmL rhulL-2 (kindly provided by Chiron. France) and/or 20 nglmL rhulL-7 (Genzyme. Cambridge. MA) were placed in 96-well flat-bottomed microplates. One to three thousand control CD34' CD7'1-or transduced SCID-X I BMC were plated to each well and cultured for 3 to 5 weeks. The medium was replaced with fresh medium with identical concentrations of cytokines every 4 days. In other experiments IL-IS (20 nglmL: a kind gift from Dr T. Troutt, Immunex. Seattle WA) was used in combination with SCF. After 3 to 5 weeks, cultures were harvested. washed. counted. and assessed for viability by trypan blue exclusion.
Cell suspensions were stained for 20 minutes with the following phycoerythrin (PE) or FITC-conjugated monoclonal antibodies (MoAbs): anti-CD7 (Leu 9: BD), anti-CD2 (leu 5b: BD) anti-CD34 (HPCA-2: BD), anti-CD19 (Leu 12: BD). anti-CD38 (Leu 17: BD). anti-CDI4 (Leu M3: BD). anti-CD16 (Leu I Ib: BD Abbreviation: ND, not done.
CD56"".
Technologies) as colony-stimulating factors. Plates were incubated at 37°C in an air atmosphere supplemented with 5% COz. Hematopoietic progenitors were scored at days 16 to 18 according to the previously described criteria."' The percentage of positively yc transduced hematopoietic precursor cells derived from PI bone marrow was evaluated in CFU methylcellulose assay. Immediately after the transduction, cells were cultured on murine stromal cells MS-5 as previously described'" in IMDM with 12.5% FCS, 12.5% horse serum (Stem Cell Technologies). Cells were maintained at 33°C 5% COz and fed weekly by half medium change. Weekly, a cellular sample was plated at a concentration of 0.5 to 2 x IO7 cells1 mL of complete methylcellulose medium (Stem Cell Technologies) as described above. At day 14, individual clones were picked and lysed. DNA was analyzed by PCR using different PCR primers to assess the yc retroviral integration and to determine among the same clones the possibility of a contamination (due to the coculture) by the neomycin gene, which is contained in the virus producing cell line. The percentage of specific yc-positive clones was calculated by subtracting the neomycin-positive clones from the total number of analyzed clones.
For yc amplification, two primers were used, one mapping into the retrovirus sequence and the other mapping into the yc chain sequence, respectively: PM-R 5'-GACCACTGATATCCTGTC-TTCAAC-3' and yc-F 5'-CCAGCCTACCAACCTCACT-3'. For neomycin amplification by PCR the following two primers were used: neo-F S'-CCATCGGCTGCTCTGATGCC-3'; neo-R 5'-GTA-DNA was amplified by PCR using 30 cycles at an annealing temperature of 60°C. PCR was performed in a 50-mL reaction mixture and a 20-mL portion of each amplified product was loaded on a I% agarose gel and electrophoresed. The PCR products were transferred and the blots hybridized with a P7'-labeled fragment of the entire coding region of yc or neomycin gene.
Total cellular RNA was extracted by using the guanidium thiocyanate method." cDNA were prepared with random hexamer primers and reverse-transcribed with a superscript kit (GIBCO BRL). Primers used for PCR were oligonucleotides recognizing sequences in the 5' and 3' regions of CD36, CD36, and CD3y and human receptor transferrin (HRT) (positive control for gene-specific amplification of cDNA): CD3e-F 5'-CTCCCCTCC-CAGCCTCAG-3' and CD3ee-R 5'-CATITACCCAGTCCATCC-3'; CD36-F S'-ACTGGATGAGTTCCGCTG-3' and CD36-R GACAGAGAC-3' and C3y-R 5'-GGAGGAGAACACCTGGAC-
Provirus inrcgruriori srudv in CFU.
A AGC ACGAGG A AGCGGT-3'.
Trunscripr unu/yis.
S'-GTTGGTAATGGCTGCTTC-3'; CD3y-F S'-TTTGCCGGA-3'; HRT-F S'-TTCCCTTCCTTCAATCACAC-3' and HRT-R 5'-To test the yc transcription after the retrovirus integration, the same two primers PM-R and yc-F were used.
cDNA was amplified for 30 cycles of PCR at 94°C for I minute; at an annealing temperature of 63°C. 56°C. 56°C. 53°C. and 60°C. respectively, for 1 minute; and 72°C for I minute. PCR was performed in a 50-pL reaction mixture, and a 20-pL portion of each amplified product was examined by 1% agaroxe gel electrophoresis and stained with ethidium bromide.
G ACTACCCTGCTGTTCTC AT-3'.
RESULTS
In vitro maturation of CD34' cord blood cells into N K cells. We first investigated conditions enabling CD34' hematopoietic progenitors to proliferate and differentiate into NK cells. Cord blood was chosen as a hematopoietic progenitor cell source as the best available age-matched cell popula- For personal use only. on October 23, 2017. by guest www.bloodjournal.org From (Table 1) . At day 0, after the double positive immunoselection, 70% of CD34' cells expressed yc chain on their surface, while only 15% of them expressed the / 3 chain and less than 1% the a chain of IL-2 receptor (data not shown). yc transcripts were also detected in the purified CD34' cells (data not shown). As shown in Table  1 , CD34+ 7' cells from cord blood could differentiate into CD56+ cells in the continuous presence of SCF + IL-2 and IL-7 for 3 weeks. These CD56+ cells coexpressed in a very limited percentage CD2 or CD16 antigens (range, 1% to 5%). In all instances, SCF was necessary to induce cell proliferation because cord blood hematopoietic precursor cells did not proliferate in the presence of IL-7 and IL-2 alone (data not shown). The best results were always obtained by the association of IL-2 with E-7, although SCF plus IL-2, could induce NK cell differentiation to a lesser magnitude (data not shown). Active proliferation occurred, as a 164-fold (230-fold) cell number increase was observed at the end of the culture period. Cells harvested at day 21 exhibited anti-K562 and ADCC cell cytotoxicity (Fig 1A) as tested on K562 and antibody-coated P815 target cells, respectively. CD34' 7-cells isolated from cord blood had a poorer ability to mature into CD56 cells in the same culture conditions and no cytotoxicity against K562 could be detected (Table l and Fig 1B) . Their proliferation index was intense, but more variable (ie, 223-fold 2 180-fold).
In the presence of SCF and IL-15, culture of CD34' CD7+'-cord blood cells differentiated into NK cells (Table  2 ) exhibiting both anti-K562 and ADCC cell cytotoxicity (Fig 1C and D) . As shown in Table 2 
28%
Ninety-five percent of CD34+ CD7' cultured cells expressed CD56 after 3 weeks and a 600-fold ( 2 173-fold) cell number increase was observed after a 3-week culture period. The vast majority of differentiated CD56' cells, strongly coexpressed CD7 (72.5% t 15%), while 16% (210%) and only 5% (52%) of them coexpressed CD16 and CD2, respectively (Fig 2) . In addition, a fraction of these cells expressed p58 (20% t 10%). SCF and IL-15 also enabled less differentiated CD34' 7-cells to give rise to functional NK cells (Fig 1D) . No cells expressed CD57 whatever the cytokine combination used.
The CD34' CD7-colony forming unit-granulocyte and macrophage cloning efficiency (CFU-GM) in methylcellulose was tested after a 3-week culture period in the presence of either SCF + IL-2, SCF + IL-7 or SCF + IL-15. The percentage of CFU-GM was respectively 12% for cells cultured with SCF + IL-2, 5% with SCF + IL-7 and only l% with SCF + IL-15, suggesting that SCF and IL-15 preferentially induced differentiation of immature cells towards the NK cell lineage. Similarly CD34' CD7', were unable to differentiate into CFU-GM after a 3-week culture with SCF + IL-15 (data not shown). Whatever the cytokine combination used, a fraction of CD34+ precursor cells differentiated into a CD16+ CD2' CD56-population. In an effort to understand the lineage commitment of this subset, these cells were purified by cell sorting and assessed for their potential toward myeloid differentiation (CFU-GM), for ADCC activity, and for expression of CD36 transcripts. These cells were unable to form (CFU-GM) colonies in vitro, while they exhibited an ADCC activity similar to that of an unselected population, CD36 transcripts could also be detected in this subset (data not shown).
yc gene transfer into yc (-) marrow cells from two SCID-X I patients. Unseparated patients' mononuclear bone marrow cells were used for transduction experiments, because the harvest sample size was limited, to minimize hematopoi- etic cell loss. Mononucleated cells previously cryopreserved were thawed the day of the experiment and immediately cultured in the presence of SCF. IL-3 and IL-6. After a 3-day coculture with irradiated I ) CRIP cells producing the MFG-B2-yc vector, yc(-), marrow cells from the two patients were further cultured in the presence of either SCF, IL-2. and IL-7 or SCF plus IL-15 to assess the possible restoration of yc expression. cell proliferation. and maturation into functional NK cells.
Immediately after yc gene transduction. 8% to 10% of bone marrow cells expressed yc at the cell surface (data not shown). As shown in Fig 3A, yc specific transcript could be detected by RT-PCR in transduced marrow cell populations tested after 2 1 to 28 days of culture in the presence of SCF + IL-2 + IL-7 or SCF + IL-15. Immunofluorescence analysis showed that a majority of cultured cells expressed yc at their cell surface (60%-and 80% for PI marrow cells cultured with IL-2 + IL-7 or IL-IS, respectively; Fig 3B) . The magnitude of expression was similar between transduced cells and control cells (ie. cord blood from a normal newborn). After mock-infection by coculture with I/J CRIP cells. no cell proliferation of CD34' yc (-) cells could be achieved in the presence of these cytokines. Cells died within 8 days of culture. In contrast, in both patients following yc gene transfer, a sevenfold cell number increase occurred after 3 weeks in the presence of both SCF + IL-2 and IL-7 or SCF + IL-15. Although before yc gene transfer virtually none of the bone marrow mononuclear cells expressed either NK cell membrane marker (Table 3) or T-cell markers (data not shown), a significant proportion of proliferating yc( +) cells from both patients' marrow samples were found to express NK cells membrane markers. ie. CD7, CD8, CD2. CD16, and CDS6 following yc gene transfer (Table 3 and Fig 4) . As soon as 2 weeks after cell culture initiation, cells expressing CD16 or CDS6 could be detected (Fig 4) . the frequency of which increased by day 21. Of note, following culture in the presence of SCF and IL-IS of transduced marrow cells from patient I. the proportion of CDS6 increased slowly as a high percentage of CDS6" cells was only noticed at day 42 (Table 4 and Fig 5) . Remarkably. significant NK and ADCC activities could be detected as tested on K562 and antibody-coated P8 IS cell lines, respectively (Fig 6) . Culture of bone marrow mononuclear cells in SCF and IL-IS was more potent in inducing maturation into fully functional NK cells (Fig 6B) as previously found with normal cord blood cells (Fig I) . CD3 6 , 5. and y chain transcripts expression was studied on these in vitro differentiated NK cells as a marker of cell differentiation3" using RT-PCR. It was compared with NK cells derived from control cord blood CD34 cells. As shown in Fig 7. whatever the cytokine combination used to induce NK cell differentiation, the cytoplasmic expression of CD3 E and 5, but not y could be detected in N K cells derived from patients' and cord blood hematopoietic precursors. These results are similar to what has been previously described in fetal NK cells.'"
Integration of yc gene following gene transfer was investigated in myeloid cell differentiation assays. Individual CFU-GM and BFU-E colonies derived from yc (-) transduced marrow cells were analyzed by PCR for yc gene integration after yc gene transfer. As shown in Fig 8. 40%-of colonies derived from PI marrow cells integrated the yc gene-containing provirus when tested after 3 weeks of culture.
DISCUSSION
In this study. we first assessed differentiation of cord blood CD34 hematopoietic progenitor cells into NK cells as a prerequisite for studying NK cell differentiation of yc (-) shown. NK cell differentiation was more efficiently achieved from more mature CD.74' CD7' than CD34' CD7-cells as a very low number of cells expressed CDS6 after a .?-week period of culture in the presence of IL-2. IL-7, and SCF of the latter population.
Because IL-IS induces proliferation and increases cytotoxicity activity of mature NK cells." we assessed the ability of IL-IS to induce cord blood CD34' cells to differentiate into mature NK cells. As reported herein. the SCF + IL-IS cytokine cocktail enabled committed CD34' CD7'. as well as immature CD34' CD7 cells from cord blood, to proliferate. to express CDS6 and other NK cell-associated markers, and to exert NK and ADCC activity. IL-IS appears as a driving force towards NK cell differentiation since cord blood CD34' cells cultured for 4 weeks in the presence of SCF and IL-IS have lost their myeloid potential as shown by the absence of maturation into CFU-GM colonies. In contrast. a proportion of the same cells cultured for 3 to 4 weeks in the presence of SCF. IL-2, and IL-7 retained the ability to grow into CFU-GM colonies. These results demonstrate that IL-IS is able to induce NK cell differentiation from cord blood hematopoietic progenitor cells when combined with SCF. Of note, Mrozeck et all" have recently reported that adult CD.74' lineage-marrow cells can differentiate into CDS6 (+) NK cells in the presence of IL-IS. At slight difference with their findings, we found that some CD16 (+) cells exhibiting ADCC activity could also differentiate in the presence of IL-IS.
The CD 16' CD2' cell population appears to be committed towards the natural killer lineage, a s it has no progenitor potential for the myeloid lineage. because it contains CD3c transcripts and kills specifically an antibody-coated target cell line. It could represent an incomplete maturation step without expression of NK cell receptors." Alternatively, it could represent a particular subpopulation of killer cells only present during early ontogeny. However. it will be necessary to confirm in other patients these results and to show that yc gene transfer into patients' CD34' cells can also restore T-cell differentiation. This is presently being assessed in a fetal thymic organ culture assay. It will also be necessary to show that a sufficient, albeit still low, number of transduced pluripotent stem cells will lead to long-term in vivo differentiation of N K and T cells given the possible selective advantage conferred to transduced cells. This hypothesis. which is supported by the in vitro selective advantage of yc (+) transduced EpsteinBarr virus (EBV)-B cells and by preliminary data in patients affected by a closely related disease ADA (-) SCID treated by gene transfer into CD34' cord blood or marrow cells'5'' needs to also be tested in vivo in animal models."
